Endurant Capital Management LP Q3 2023 significant ownership

Endurant Capital Management LP is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Endurant Capital Management LP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
AZIYO BIOLOGICS, INC.	March 21, 2023	576,253	4.9%
Oxford Immunotec Global PLC^{Sold out}	February 17, 2021	0	0.0%

Compare quarters

Export Endurant Capital Management LP's holdings